Advisors Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-61,738
| Closed | -$645K | – | 1493 |
|
2022
Q3 | $645K | Sell |
61,738
-1,552
| -2% | -$16.2K | 0.01% | 868 |
|
2022
Q2 | $680K | Sell |
63,290
-13,194
| -17% | -$142K | 0.01% | 871 |
|
2022
Q1 | $724K | Sell |
76,484
-4,997
| -6% | -$47.3K | 0.01% | 895 |
|
2021
Q4 | $941K | Sell |
81,481
-1,345
| -2% | -$15.5K | 0.01% | 844 |
|
2021
Q3 | $791K | Sell |
82,826
-500
| -0.6% | -$4.78K | 0.01% | 891 |
|
2021
Q2 | $803K | Buy |
83,326
+4,574
| +6% | +$44.1K | 0.01% | 894 |
|
2021
Q1 | $778K | Buy |
78,752
+33,181
| +73% | +$328K | 0.01% | 902 |
|
2020
Q4 | $1.05M | Buy |
45,571
+30,874
| +210% | +$713K | 0.02% | 764 |
|
2020
Q3 | $208K | Buy |
14,697
+6,808
| +86% | +$96.4K | ﹤0.01% | 1171 |
|
2020
Q2 | $119K | Buy |
+7,889
| New | +$119K | ﹤0.01% | 1266 |
|